This research developed NanoX, a nanoscale fluorescent sensor that images oxytocin release from individual neurons in real time. By revealing patterns of brain chemistry associated with mental health disorders, the technology could enable earlier diagnosis, improve understanding of neurochemical signaling, and support both preventive and personalized mental healthcare.

This research shows that early-life oxytocin treatment can reverse key features of fragile X syndrome in mice. Brief intervention strengthens neural connections, normalizes learning and social behavior, and prevents seizures into adulthood. The findings suggest oxytocin may offer a safe, early intervention strategy for fragile X and other intellectual disabilities.